Technology

MeiraGTx

$15.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (+2.29%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MeiraGTx and other stocks, options, and ETFs commission-free!

About MGTX

MeiraGTx Holdings plc Ordinary Shares, also called MeiraGTx, is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY. The listed name for MGTX is MeiraGTx Holdings plc Ordinary Shares.

CEO
Alexandria Forbes
Employees
157
Headquarters
New York, New York
Founded
2015
Market Cap
698.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
100.55K
High Today
$15.83
Low Today
$14.72
Open Price
$15.34
Volume
98.29K
52 Week High
$21.77
52 Week Low
$8.82

Collections

MGTX Earnings

-$1.34
-$0.89
-$0.45
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, Pre-Market

You May Also Like

SZC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure